Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. Article uri icon

Overview

publication date

  • October 1, 2020

Research

keywords

  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Quality of Life

Identity

PubMed Central ID

  • PMC7556659

Scopus Document Identifier

  • 85092253983

Digital Object Identifier (DOI)

  • 10.3324/haematol.2019.238808

PubMed ID

  • 33054096

Additional Document Info

volume

  • 105

issue

  • 10